Form 483

Konsyl Pharmaceuticals Inc Form 483, 2012-05-31

FDA issued a Form 483 to Konsyl Pharmaceuticals Inc on 2012-05-31 with 8 public-safe observations.

483· Form 483 issued8 observations

Konsyl Pharmaceuticals Inc · Easton, United States · Issued May 31, 2012

Overview

  • 8 public-safe observations are available for this inspection.
  • 8 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

31 May 2012
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Rachel C Harrington, Nebil A Oumer

31 May 2012
21 CFR 211.58

Buildings not maintained in good state of repair

Cited by Rachel C Harrington, Nebil A Oumer

31 May 2012
21 CFR 211.68(a)

Written calibration / inspection records not kept

Cited by Rachel C Harrington, Nebil A Oumer

31 May 2012
21 CFR 211.84(d)(2)

Reports of Analysis (Components)

Cited by Rachel C Harrington, Nebil A Oumer

31 May 2012
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Rachel C Harrington, Nebil A Oumer

Inspected site

KPKonsyl Pharmaceuticals IncEaston, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.165(e)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.58Cited across public-safe Form 483 observations1x
21 CFR 211.68(a)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(2)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 8 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere